View Cart  

Mylan Sues FDA Over Exclusivity on Diovan Generics

A A
Mylan is suing the FDA over its refusal to grant 180-day exclusivity for the company’s four generic versions of Novartis’ high blood pressure drug Diovan.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00